Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18465
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHennessey, Derek B-
dc.contributor.authorHoag, Nathan-
dc.contributor.authorGani, Johan-
dc.date.accessioned2018-08-30T06:04:45Z-
dc.date.available2018-08-30T06:04:45Z-
dc.date.issued2017-07-
dc.identifier.citationTranslational andrology and urology 2017; 6(Suppl 2): S103-S111-
dc.identifier.issn2223-4691-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/18465-
dc.description.abstractBladder dysfunction is a relatively common urodynamic finding post radical prostatectomy (RP). It can be the sole cause of post prostatectomy incontinence (PPI) or may be found in association with stress urinary incontinence (SUI). The aim of this review is to provide a comprehensive review of the diagnosis and different treatments of post RP bladder dysfunction. A comprehensive literature review using medical search engines was performed. The search included a combination of the following terms, PPI, detrusor overactivity (DO), detrusor underactivity (DU), impaired compliance, anticholinergic, onabotulinumtoxinA (Botox®) and sacral neuromodulation (SNM). Definitions, general overview and management options were extracted from the relevant medical literature. DO, DU and impaired compliance are common and may occur alone or in combination with SUI. In some patients the conditions exist pre RP, in others they arise due to denervation and surgical changes. DO can be treated with anticholinergics, Botox® and SNM. DO may need to be treated before SUI surgery. DU may be a contraindication to male sling surgery as some patients may go into urinary retention. Severely impaired bladder compliance may be a contraindication to SUI surgery as the upper tracts may be at risk. Each individual dysfunction may affect the outcome of PPI treatments and clinicians should be alert to managing bladder dysfunction in PPI patients.-
dc.language.isoeng-
dc.subjectPost prostatectomy incontinence (PPI)-
dc.subjectanticholinergic-
dc.subjectdetrusor overactivity (DO)-
dc.subjectdetrusor underactivity (DU)-
dc.subjectimpaired compliance-
dc.subjectonabotulinumtoxinA-
dc.subjectsacral neuromodulation (SNM)-
dc.titleImpact of bladder dysfunction in the management of post radical prostatectomy stress urinary incontinence-a review.-
dc.typeJournal Article-
dc.identifier.journaltitleTranslational andrology and urology-
dc.identifier.affiliationDepartment of Urology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Urology, Victoria General Hospital, Victoria, British Columbia, Canadaen
dc.identifier.affiliationDepartment of Urology, Western Health, Footscray, Victoria, Australiaen
dc.identifier.doi10.21037/tau.2017.04.14-
dc.identifier.orcid0000-0002-7372-0100-
dc.identifier.pubmedid28791229-
dc.type.austinJournal Article-
dc.type.austinReview-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
crisitem.author.deptUrology-
crisitem.author.deptSurgery (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Jan 29, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.